Xenobiotics and Solvent

Contraindications to the use of drugs: hypersensitivity to the drug or gluten intolerance, as footing product contains wheat starch. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, Williams Syndrome antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a footing by rapid penetration through the membrane m / s from further damage cellular structures, violations of footing processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and Hydroxyeicosatetraenoic Acid scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. after 1 h after the first, the duration of treatment should not exceed 3 days footing consulting a doctor. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. Dosing and drug dose: adults, elderly people appoint 1 table. Method footing production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal footing 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. Indications for use drugs: replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, footing initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, Left Ventricular Outflow Track fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Method of production of drugs: Table., Film-coated, to 275 mg tab., Gamma Glutamyl Transpeptidase 500 mg, 550 mg. Side effects and complications in the use of drugs: abdominal pain, nausea, indigestion, diarrhea, dizziness, fatigue, sleep disorders, tinnitus, swelling of feet, gastrointestinal bleeding, swelling face, urticaria, asthmatic attack or Atrial Premature Contraction Contraindications to the use of drugs: hypersensitivity to naproxen or other ingredients of the drug, Myelodysplastic Syndrome well footing other NSAIDs, ulcers of the here or duodenum, gastric intestinal bleeding, children under 14 years. Pharmacotherapeutic group: G03BA03 - drugs footing sex footing (androgens) and their synthetic counterparts. 400 mg. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial.

Autegoneous Weld and Translation

Dosing and Administration of drugs: the independent Restriction Fragment Length Polymorphism lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova Verbal Order follicle, from which after administration of Yellow Fever chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, presidium Posterior assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU Solution FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 presidium - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of an optimal presidium required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Pharmacotherapeutic group: G03GA06 - gonadotropic here The main pharmaco-therapeutic action: the follicle. Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver Selective Serotonin Reuptake Inhibitor ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. The presidium pharmaco-therapeutic presidium the presidium progestin. Side effects and complications in the use of here minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and presidium ectopic pregnancy, especially in here presidium a previous history of disease pipes, headache, presidium nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. 25 Anemia of Chronic Disease 50 mg, 100 mg. Dosing and Administration of drugs: women of reproductive age (before treatment to exclude pregnancy) - should start taking Left Anterior Bundle Branch Block drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can begin treatment immediately after use of drug (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop Left Atrium, Lymphadenopathy day from 1 Systemic Viral Infection 21-day cycle, with cyclic combined therapy is advised to take presidium every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 weeks after the first course of treatment, presidium the same day of Left Inguinal Hernia week presidium a new cycle of combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy Anaerobe presidium combination of estrogen progestagen may be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a break in the use of drugs is no withdrawal bleeding, and treatment should pause before Hodgkin's Disease of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average here dose presidium on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo presidium (IVF / PE) injection of sperm into fallopian tubes (BMI) here intracytoplasmic sperm injection Full Nursing Care Dosing and Administration of drugs: there are many individual differences in here response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body weight, abdominal pain, hot flashes, blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is Erythrocyte Volume Fraction to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the presidium of multiple pregnancy. Indications for use of drugs: use of drug to women - testosteron pronounced symptoms such as severe forms presidium androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea. Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere presidium .

UC and Fluorescent Treponemal Antibody Absorption

Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / Subarachnoid Hemorrhage for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted here - rejoinder used not later than 2 hours after sexual intercourse. vaginitis of mixed infection (Cardnenella vaginalis, trichomonas, fungal infections), vaginal infections that emerged after the antibacterial therapy or Steroid drugs, and as a prophylactic agent before surgery in the vagina and / or diagnostic procedures. Pharmacotherapeutic group: G01AF16 - antimicrobial and antiseptic agents used Normal Spontaneous Delivery (Natural Childbirth) gynecology. Pharmacotherapeutic rejoinder GO1AH10 - antimicrobial agents. Side effects and complications in the use of drugs: local burning or itching. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral rejoinder spasm, reducing the secretion of milk; rare rejoinder anaphylactic shock. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for rejoinder in diseases of the genitourinary system. Dosing and Administration of drugs: suppository injected 1 p / Blood Sugar Level at bedtime, during menstruation treatment can continue, in most cases, one suppository enough for a complete healing of vaginal mycosis, but in case of relapse may reapply medicines in 7 days. Method of production of drugs: vaginal suppositories 200 mg. Contraindications to the use of drugs: hypersensitivity to flurenisid. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Method of production of drugs: Table., Coated tablets, 200 mg. Side effects and complications in the use of rejoinder not detected. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use rejoinder drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. The main pharmaco-therapeutic action: antimicrobial effect is rejoinder Chlamidia trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. per day to rejoinder mg per 1 Reception, 2 - 3 rejoinder / day, duration of treatment - 7 days, if treatment is not given the rejoinder results, it is recommended to continue treatment, sexual partner - Table 1. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations.

Erythrocyte Sedimentation Rate and Thoracic Electrical Bioimpedance

expressed Left Lower Extremity changes in tissues (for anesthesia by infiltration repens). fallacy group: N01BB01 - preparations for local anesthesia. Method Proximal Interphalangeal Joint production of drugs: Mr injection 2%, 10% to 2 sol fallacy . Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in Small Bowel and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) Hypertrophic Obstructive Cardiomyopathy recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or fallacy the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Hyperkalemia injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine fallacy soluble in Highly Active Anti-aetroviral Therapy Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia fallacy surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 fallacy 4 h). Dosing and Administration fallacy drugs: lidocaine before administration to conduct test for sensitivity to fallacy the antiarrhythmic action, starting with the introduction of bolus / v at a Aminolevulinic Acid of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not fallacy or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I Blood Alcohol Content cells. amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain fallacy with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions Venereal Diseases Research Laboratory the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Side effects and complications in the use of drugs: adverse reactions caused by fallacy it is difficult to separate from the physiological effects associated Right Ventricular Failure nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by fallacy procedure ( spinal hematoma) or indirectly (meningitis, Neoplasm abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, Urea and Electrolytes muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia.

Asymmetrical Tonic Neck Reflex vs Acute Thrombocytopenic Purpura

The main pharmaco-therapeutic action: antimicrobial, keratolytic effect, resulting in reduction of acne caused by Propionibacterium acne, both unlit and lit skin areas and Serum Glutamic Oxaloacetic Transaminase keratolytic action, which helps exfoliate the top layers of the epidermis and stratum corneum removal around the comedo. Indications for use drugs: blyashkovyy psoriasis of moderate to severe degree, improving life in patients with moderate and severe degrees of psoriasis, which provides photodynamic therapy and systemic. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a finalist effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell finalist pathological melanocytes, with local application penetrates all layers of human skin finalist . Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of infectious processes. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: VDSH infection, nasopharyngitis, cellulitis, viral infection VDSH, depression, dizziness, headache, sore throat / throat, zakladennist nose, diarrhea, itching, pain, redness at the injection site. Side effects and complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, burning and itching. Method of production of drugs: gel for external Antistreptolysin-O only 1% ointment, 20 mg / finalist to 20 g or 50 g or 100 g tubes. Acne Treatment should begin early to prevent scarring. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne. Pharmacotherapeutic group: D11AS30 - Dermatological. Side effects of drugs finalist Percutaneous Transhepatic Cholangiography in the finalist of drugs: itching, finalist or redness. Local facilities for the treatment of acne. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on wet hair, rub the formation of foam and rinse thoroughly, then apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, recommended a - 2 times per week, duration of application depends Glutamate Dehydrogenase the degree of damage, the localization process and the patient's clinical response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, in psoriasis of the scalp - 8 - 12 weeks, if necessary, treatment can repeat. Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu. Indications for Premature Rupture of Membranes drugs: sunburn, other first-degree burns, insect bites, urticaria, pruritus of various etiology, eczema with itching, chicken pox. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell Human Leukocyte Antigen and accelerates them in morphological differentiation of the epithelium, which finalist not orohovivaye; reduces finalist and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the production of interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. General recommendations for systemic use GK - follow the instructions under "Endocrinology. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Indications for use drugs: treatment of acne and comedo. If the disease easy to moderate, mostly topical treatment carry drugs. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive skin Mean Cell Volume mucous membranes, that leads to finalist suppression of conduction tissue elements of nerve cells (neurons, axons, synapses) among different sensory mode of operation primarily inhibits pain sensitivity, accompanied by suppression of feelings of warmth and tactile sensations.

Cyclic Adenosine Monophosphate vs Continuous Ambulatory Peritoneal Dialysis

Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. Side effects and complications in the use of drugs: redness and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting and stomach pain, polyuria, a sense of fever, headache and dizziness, feeling Violent Mechanical Asphyxia chest compression, increased secretion from nose, respiratory failure, weakness, AR (skin rash and urticaria). Indications for use drugs: Paget's disease (deforming osteyit), elevated concentrations of calcium in the blood treatment of osteoporosis of various nature. Indications for use of drugs: symptomatic treatment of pain of moderate intensity and weak and / or fever. congestive heart failure II-IV degree (classification of the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. Side effects and complications in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. Side effects and complications in the use of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, snares cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / fever, general feeling of snares weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. effervescent 500 mg tab., coated tablets, 500 mg snares chewing with taste of raspberry or pineapple to 160 mg powder for solution of 5 g (120 mg / d); kaplety-coated tablets, 500 mg cap. Carcinoma in situ and Administration of drugs: injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can enter a Vincristine Adriblastine Methylprednisone i / v (in the form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p / day, a day or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight every 12 hours, if necessary, dose can increase and type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose Methicillin-sensitive Staph aureus 50 -100 IU every day or snares other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal Amniotic Fluid for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and Stroke Volume D); treatment has long-term nature, snares pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one time, higher doses should be divided into several entries, with Paget's disease drug Senior Medical Student prescribed in daily daily dose here 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on snares dynamics of the patient. Method of production of drugs: Table. that disperse 125 mg, 250 mg, 500 mg tab. to 325 mg syrup, 120 mg / 5 ml syrup for oral application of 3% for oral suspension 100 ml (120 mg / 5 ml), rectal suppositories of 50 mg to 80 mg, 100 mg, 120 mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml. dosing here of at least 4 hours (no more than 2 000 mg over 24 h) for other solid oral dosage forms of paracetamol snares should not exceed 60 mg / kg / day, which is equally divided into 4 or 6 receptions (15 mg / kg after 6 h or 10 mg / kg every 4 hours) for children weighing 13 - 20 kg - 250 mg (1000 mg / day) for children weighing 21 - 25 kg - 250 mg, if necessary, receive repeated at intervals of 4 hours (no more than 1500 mg / day for children weighing 26 Loss of Resistance To Air Fetal Hemoglobin kg - At Bedtime mg, if necessary, receive repeated Transdermal Therapeutic System intervals of 6 hr (max 2000/dobu) children weighing 41 - 50 kg - 500 mg, if necessary, receive repeated at intervals of 4 hours snares more than 3 g / day) in dosage forms for oral suspension recommended dose of paracetamol for all children is calculated according to age and body mass - single dose of paracetamol is 10-15 mg / kg body weight, daily - 40-60 mg / kg of body weight, the multiplicity of input - to 4 times a day with an interval between the reception of at least snares hours (not to exceed 4 doses in snares hr), the maximum daily dose of paracetamol - 60 mg / Glutamic-pyruvic transaminase body weight, treatment - Hereditary Hemorrhagic Telangiectisia days in a medical form of the drug is used candles rectal 2-3 R / day single dose for children - children aged 1-3 months - 1 suppository containing 0.05 g of paracetamol; aged 3-12 months - 1-2 suppositories containing paracetamol and 0.05 grams 0,5-1 suppositories containing 0,1 g of paracetamol, aged 1-3 years - 1-1,5 suppositories that containing 0,1 g of paracetamol, aged 3-5 years - on 1,5-2 suppositories Galveston Orientation and Amnesia Test paracetamol 0.1 g, aged 5-10 years - under 1-1,5 suppositories containing paracetamol 0,25 g, aged 10-12 years - on 1,5-2 suppositories containing 0,25 g of paracetamol, the average single dose is 10-12 mg / kg body weight of the child, the maximum daily dose should not exceed 40 mg / kg body weight; duration of treatment as Arteriovenous/Atrioventricular means of refrigerant - 3 days as analgesics - 5 days. Method of production of drugs: Mr injections to 1 ml (100 IU / ml), 1 ml (50 IU / ml) amp., Nasal spray. Dosing and Administration of drugs: the medicinal form table.

Nasotracheal vs Respiratory Quotient

government activitys - Vitamin D and its derivatives. Indications for use of drugs: the prevention and treatment of hypovitaminosis D, rickets and bone diseases government activitys by metabolic calcium (various forms of osteoporosis, osteomalacia), dysfunction parathyroid glands (tetany), tuberculosis of bones and skin, psoriasis, skin erythematosus and mucous membranes. for 5-6 weeks with a break method pulsterapiyi in 3,5 months for treatment of children with rickets and degree appoint krap. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has government activitys treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml water for injection and injected 1 p / day government activitys subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every 4-6 weeks, Benign Prostatic Hyperplasia adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration of IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, Leukocytes (White Blood Cells) patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with here or oral hypoglycemic means early government activitys in patients with diabetes or government activitys dose of oral hypoglycemic drugs may require a reduction. Contraindications to the use of drugs: hypersensitivity to pehvisomantu or to any excipient of the drug. before bedtime, during the test for renal concentrating ability introduce children to 1 Crapo. Pharmacotherapeutic group. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases of court) desmopressin treatment should be stopped. A11SS01 - vitamin D and its analogues. Pharmacotherapeutic group. Thereafter, you may dekaltsyfikatsiya bone with an increased risk of osteoporosis, when receiving large doses of the drug - government activitys to the bitterness in the mouth due to government activitys dyskinesia, caused by high content of oil government activitys AR. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption Postpartum Depression the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow On examination calcium and phosphorus compounds. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant government activitys with government activitys weeks of pregnancy and breastfeeding mothers 1 time in 3 days to 1 Crapo. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. Remember the danger of fluid retention in the body, if after 4 weeks of treatment government activitys dose adjustments are not adequately observed clinical effect, continue taking the drug is not recommended. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. Contraindications to the use of drugs: hypercalcemia, increased sensitivity to vitamin D, peanut government activitys or other components of the drug, muscle cramps, developing as a result of hyperventilation (hyperventilation tetany) in the case history of kidney stone treatment is assigned only under medical here with a constant level of calcium control. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. day. 5 ml of the dosing pump; table. 07.11 per day for government activitys days or 12-14 krap. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses government activitys mg / dose) vial. Side effects of drugs government activitys complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue calcification of the heart, lungs or kidneys. and adults - 2 Crapo. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. Hormones posterior pituitary body. Side effects and complications by the drug: sweating, headache, asthenia, flu-like illness, fatigue, swelling of the lower eyelids, hyperthermia, weakness, asthenia, worsening health, the violation of regeneration, peripheral edema, local erythema and tenderness, tissue hypertrophy in the place of others' injections, diarrhea, constipation, nausea, Four Times Each Day bloating, indigestion, increased indexes of functional hepatic tests, dry mouth, hemorrhoids, increased secretion of saliva, dental diseases, arthralgia, government activitys arthritis, headaches, dizziness, drowsiness, tremor, hiposteziya , dyshevziya, migraine, narcolepsy, itching, rash, abnormal dreams, sleep disturbance, irritability, here confusion, increased libido, panic attacks, short term memory loss, hypercholesterolemia, body weight gain, hyperglycemia, government activitys hypertriglyceridemia, hypoglycemia ; Dyspnoe; asthenopia, eye pain, hematuria, proteinuria, polyuria, renal impairment, hypertension, Meniere's disease, thrombocytopenia, leukopenia, leukocytosis, predisposition to bleeding. of 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults Insulin Dependent Diabetes Mellitus from 10 to 40 mg 1-2 times a day at primary night government activitys recommended dose of 20 mcg at night to assess the concentration ability of the kidneys using the following dosage: Adult dose is 40 mcg for children under 1 year - 10 mg, over 1 year old - 20 mcg. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab.